Züchner S, Gilbert J R, Martin E R, Leon-Guerrero C R, Xu P-T, Browning C, Bronson P G, Whitehead P, Schmechel D E, Haines J L, Pericak-Vance M A
Miami Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Ann Hum Genet. 2008 Nov;72(Pt 6):725-31. doi: 10.1111/j.1469-1809.2008.00474.x. Epub 2008 Aug 28.
A chromosomal locus for late-onset Alzheimer disease (LOAD) has previously been mapped to 9p21.3. The most significant results were reported in a sample of autopsy-confirmed families. Linkage to this locus has been independently confirmed in AD families from a consanguineous Israeli-Arab community. In the present study we analyzed an expanded clinical sample of 674 late-onset AD families, independently ascertained by three different consortia. Sample subsets were stratified by site and autopsy-confirmation. Linkage analysis of a dense array of SNPs across the chromosomal locus revealed the most significant results in the 166 autopsy-confirmed families of the NIMH sample. Peak HLOD scores of 4.95 at D9S741 and 2.81 at the nearby SNP rs2772677 were obtained in a dominant model. The linked region included the cyclin-dependent kinase inhibitor 2A gene (CDKN2A), which has been suggested as an AD candidate gene. By re-sequencing all exons in the vicinity of CDKN2A in 48 AD cases, we identified and genotyped four novel SNPs, including a non-synonymous, a synonymous, and two variations located in untranslated RNA sequences. Family-based allelic and genotypic association analysis yielded significant results in CDKN2A (rs11515: PDT p = 0.003, genotype-PDT p = 0.014). We conclude that CDKN2A is a promising new candidate gene potentially contributing to AD susceptibility on chromosome 9p.
迟发性阿尔茨海默病(LOAD)的一个染色体位点先前已被定位到9p21.3。在经尸检确诊的家系样本中报告了最显著的结果。在一个有血缘关系的以色列 - 阿拉伯社区的AD家系中,已独立证实与该位点存在连锁关系。在本研究中,我们分析了由三个不同联盟独立确定的674个迟发性AD家系的扩大临床样本。样本子集按地点和尸检确诊情况进行分层。对该染色体位点上密集的单核苷酸多态性(SNP)阵列进行连锁分析,在NIMH样本的166个经尸检确诊的家系中得到了最显著的结果。在显性模型中,D9S741处的最高全基因组连锁优势对数(HLOD)得分是4.95,附近的SNP rs2772677处为2.81。连锁区域包括细胞周期蛋白依赖性激酶抑制剂2A基因(CDKN2A),该基因已被认为是一个AD候选基因。通过对48例AD病例中CDKN2A附近的所有外显子进行重测序,我们鉴定并对四个新的SNP进行了基因分型,包括一个非同义、一个同义以及两个位于非翻译RNA序列中的变异。基于家系的等位基因和基因型关联分析在CDKN2A中产生了显著结果(rs11515:传递不平衡检验(PDT)p = 0.003,基因型 - PDT p = 0.014)。我们得出结论,CDKN2A是一个有前景的新候选基因,可能对9号染色体上的AD易感性有贡献。